ADXN Buy or Sell? There is not enough analysis data for Addex Therapeutics. Addex shares trade on the SIX Swiss Exchange main board under the stock symbol ADXN (ISIN: CH0029850754). investment rating View the latest market news and prices, and trading information. © 2020 Cable News Network. (Add your “underperform” vote.). Addex Therapeutics is scheduled to release its next quarterly earnings announcement on Wednesday, May 19th 2021. Learn more. Get Our PREMIUM Forecast Now, from ONLY $7.49! All times are ET. MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Addex Therapeutics Ltd (ADXN:NAQ) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates. ADXN 11.07 0.34 (3.17%). MarketBeat just released five new trading ideas, but Addex Therapeutics wasn't one of them. View Addex Therapeutics' Short Interest. Addex Therapeutics' management team includes the following people: Start Your Risk-Free Trial Subscription Here, Editor of top German newspaper suspended in compliance probe, Timing key in consulting deal between FirstEnergy, regulator, You Must Recognize Your Own Achievements First Before Expecting Others To, The Latest: Paris may face new lockdown as ICUs fill up, 'Big burden' for schools trying to give kids internet access, The Latest: Pakistan imposes partial lockdown in some areas, Three Mall Retailers For Your Reopening Watchlist, 3 Growth Stocks with Above Market Dividend Yields, 3 Best Stocks to Buy That You’ve Probably Never Heard Of, Ferroglobe Will Get a Big Lift From Demand For Silcon Wafers, Blue Bird Stock is a Dual Tailwinds EV and Re-Opening Play, Nautilus Stock is a Pullback Buying Opportunity Here, The Launch of Truforma Should Send Zomedica to An All-Time High, Defi Markets Pause But New Highs Are In Sight, 7 Stocks That Cathie Wood is Buying And You Should Too, 7 Internet of Things Stocks That Are a Perfect Fit to Our Connected Future, 7 Undervalued Stocks That Deserve More Attention, 7 Semiconductor Stocks Set to Gain From the Chip Shortage, 7 Great Dividend Stocks to Buy For a Comfortable Retirement, 7 Penny Stocks That Don’t Care About Robinhood, 7 Hotel Stocks Just Waiting For the Vaccine, 7 Stocks to Watch When Student Debt Forgiveness Gets Passed, 7 Healthcare Stocks Delivering Innovation in 2021, 7 Lithium Stocks That Will Power the Electric Vehicle Boom, Addex Therapeutics Limited (ADXN) CEO Tim Dyer on Q4 2020 Results - Earnings Call Transcript, Addex Therapeutics to Release Full-Year 2020 Financial Results and Host Conference Call on March 11, 2021, Addex to Present at the H.C. Wainwright Global Life Sciences Conference, Enamine Extend Collaboration With Prominent Swiss Biotech, Addex Provides Trading Update and Completes 2020 with Strong Cash Position of CHF18.7 million, Addex GABAB Positive Allosteric Modulator Demonstrates Promise in Alcohol Use Disorder, Stock Alert: Addex Therapeutics Soars 40%, The Daily Biotech Pulse: Addex Jumps On Positive Data For Out-Licensed Drug, COVID-19 Vaccine Developer Inovio Announces $150M Follow-On Offering, Boston Scientific Goes Shopping, Addex ADX71149 Receives IND Approval to Start a Phase 2a Clinical Study in Epilepsy, Addex Successfully Completes $11.5 Million Capital Increase Including Full Exercise of Underwriter's Option to Purchase Additional Securities, Addex to Present at the Baader Helvea Swiss Equities Conference, Addex Successfully Completes $11.5 Million Capital Increase Including Full Exercise of Underwriter’s Option to Purchase Additional Securities, Addex Announces Pricing of $10.0 Million Global Offering, Why Is It Moving? Get a free ADXN technical analysis report to make a better ADXN stock predictions on how the stock will perform in the near future. Addex Therapeutics Ltd (ADXN:SWX) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates. Learn about financial terms, types of investments, trading strategies and more. View real-time stock prices and stock quotes for a full financial overview. Find market predictions, ADXN financials and market news. Analyzing The Downward Movement in Addex Therapeutics's Stock Today, Addex Announces Filing of Registration Statement for Proposed Public Offering of Securities, Addex Reports Q3 2020 Financial Results and Provides Corporate Update, ADDEX THERAPEUTICS TO RELEASE Q3 2020 FINANCIAL RESULTS AND HOST CONFERENCE CALL ON NOVEMBER 3rd, 2020, Addex to Present at the Investora Conference, Van Leeuwenhoeck Issues Updated Addex Equity Research Report, Receive Analysts' Upgrades and Downgrades Daily. Date Range. ADXN stock was acquired by a variety of institutional investors in the last quarter, including Caxton Corp. One share of ADXN stock can currently be purchased for approximately $10.79. As of February 12th, there was short interest totaling 4,200 shares, a drop of 67.9% from the January 28th total of 13,100 shares. Fundamental company data provided by Zacks Investment Research. View all of ADXN's competitors. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. ADXN | A complete ADXN overview by MarketWatch. It has license and collaboration agreement with Janssen Pharmaceuticals Inc. to develop mGluR2PAM compounds for the treatment of human health. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. ADXN -- USA Stock : USD 11.76 0.37 3.25% : Addex Therapeutics Stock Forecast is based on your current time horizon. Sign-up to receive the latest news and ratings for ADXN and its competitors with MarketBeat's FREE daily newsletter. About the Addex Therapeutics Ltd. stock forecast Unlock SECRET Features HERE! Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Receive a free world-class investing education from MarketBeat. See the latest Addex Therapeutics Ltd ADR (ADXN) stock analysis, price, forecast, news and more. Some companies that are related to Addex Therapeutics include Theratechnologies (THERF), Abeona Therapeutics (ABEO), Osmotica Pharmaceuticals (OSMT), Onconova Therapeutics (ONTX), Genprex (GNPX), Enlivex Therapeutics (ENLV), Mustang Bio (MBIO), Milestone Pharmaceuticals (MIST), vTv Therapeutics (VTVT), ObsEva (OBSV), Exicure (XCUR), Metacrine (MTCR), Harrow Health (HROW), Medicenna Therapeutics (MDNA) and Aptinyx (APTX). Bollinger Bands consist of a set of three curves drawn in relation to securities prices. Morningstar: © 2019 Morningstar, Inc. All Rights Reserved. Addex Therapeutics stock forecast & analyst price target predictions based on a number of analysts offering 12-months price targets for ADXN in the last 3 months. See ADDEX N (ADXN.SW) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. Email * Constant Contact Use. P.O.Box 790260. Our Accessibility Statement Please log in to your account or sign up in order to add this asset to your watchlist. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 Close price at the end of the last trading day (Wednesday, 3rd Mar 2021) of the ADXN.SW stock was 1.76 Fr. Addex Therapeutics is headquartered at CHEMIN DES AULX 12 PLAN-LES-OUATES, GENEVA V8, CH-1228. Get daily stock ideas top-performing Wall Street analysts. No recent news for Addex Therapeutics Ltd. MarketBeat's community ratings are surveys of what our community members think about Addex Therapeutics and other stocks. Bollinger Bands charts for ADXN.SW (Addex Therapeutics Ltd). In the medium term (3months), ADXS's stock price should outperform the market by 7.31%. Addex Therapeutics does not currently pay a dividend. View today's stock price, news and analysis for Addex Therapeutics Ltd. (ADXN). Looking for new stock ideas? View our earnings forecast for Addex Therapeutics. Export data to Excel for your own analysis. Addex Therapeutics Ltd () Stock Market info Recommendations: Buy or sell Addex Therapeutics stock? Based on our forecasts, a long-term increase is expected, the "ADXN" stock price prognosis for 2026-03-06 is 26.941 USD. Advaxis' stock was trading at $0.6666 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). A Warner Media Company. Based on an average daily trading volume, of 111,200 shares, the days-to-cover ratio is presently 0.0 days. ADXN | Complete Addex Therapeutics Ltd. stock news by MarketWatch. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. Based on aggregate information from My MarketBeat watchlists, some companies that other Addex Therapeutics investors own include Achillion Pharmaceuticals (ACHN), Aurora Cannabis (ACB), ACADIA Pharmaceuticals (ACAD), Arbutus Biopharma (ABUS), Abacus Property Group (ABP), Advanced Biomedical Technologies (ABMT), Abiomed (ABMD), ARCA biopharma (ABIO), Abeona Therapeutics (ABEO) and Abcam (ABCZY). Based on an average daily volume of 114,100 shares, the short-interest ratio is presently 0.1 days. (Add your “outperform” vote. The current stock price of Addex Therapeutics Ltd is $12.30; ADXN stock price opened the day at $12.5 after previous close of $11.52; During the day, Addex Therapeutics Ltd stock quote has varied from a low of $11.82 to a high of $12.64; Addex Therapeutics Ltd Share Price: 52-Week You may vote once every thirty days. Addex Therapeutics Stock Forecast is based on your current time horizon. The company can be reached via phone at 41 22 884 1555. This is 2.03% more than the trading day before Tuesday, 2nd Mar 2021. © American Consumer News, LLC dba MarketBeat® 2010-2021. ADXN: Get the latest Addex Therapeutics stock price and detailed information including ADXN news, historical charts and realtime prices. Currently there are 39,748,635 shares (including treasury shares) outstanding. Addex Therapeutics does not have a long track record of dividend growth. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. All Rights Reserved. © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Find real-time ADXS - Advaxis Inc stock quotes, company profile, news and forecasts from CNN Business. The ADXN stock forecast is provided by MarketClub with their Trade Triangle system.. ADXN Stock … Investors can use this forecasting interface to forecast Addex Therapeutics historical stock prices and determine the direction of Addex Therapeutics's future trends based on various well-known forecasting models. Addex Therapeutics Ltd - ADR NASDAQ Updated Mar 11, 2021 12:36 AM. Who are Advaxis' key executives? Learn everything you need to know about successful options trading with this three-part video course. Find real-time ADXN - Addex Therapeutics Ltd stock quotes, company profile, news and forecasts from CNN Business. Stock screener for investors and traders, financial visualizations. Addex Therapeutics Ltd American Depositary Shares (ADXN) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. In the past three months, Addex Therapeutics insiders have not sold or bought any company stock. Wall Street analysts have given Addex Therapeutics a "N/A" rating, but there may be better short-term opportunities in the market. CNN Sans™ & © 2016 Cable News Network. Get short term trading ideas from the MarketBeat Idea Engine. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. You can opt out at any time. Addex Therapeutics has received 0 “outperform” votes. The official website for Addex Therapeutics is www.addextherapeutics.com. The company was formerly known as Addex Pharmaceuticals Ltd and changed its name to Addex Therapeutics Ltd in March 2012. Addex Therapeutics saw a increase in short interest during the month of February. This NYC Startup Raises $51M to Disrupt the Retirement Industry, 5 Social Security Mistakes to Avoid At All Costs, 7 Mistakes That Will Ruin Your Retirement Income, 7 Retirement Secrets Smart Americans Should Know, You Can Still Buy This "Millionaire Maker" Stock, Bitcoin Up 30,000X -- Here's Your Backdoor In, This Stock Could Be Like Buying Amazon for $3.19. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. View our full suite of financial calendars and market data tables, all for free. Thinking about buying or selling stock in ADXN? Vote “Outperform” if you believe ADXN will outperform the S&P 500 over the long term. Stock analysis for Addex Therapeutics Ltd (ADXN:SIX Swiss Ex) including stock price, stock chart, company news, key statistics, fundamentals and company profile. View live ADDEX N chart to track its stock's price action. Addex Therapeutics Ltd, a development-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule pharmaceutical products for central nervous system (CNS) disorders in Switzerland. ADXS stock forecast Our latest prediction for Advaxis, Inc.'s stock price was made on the Feb. 2, 2018 when the stock price was at 2.90$.. To see all exchange delays and terms of use please see disclaimer. During the day the stock fluctuated 5.59% from a day low at 1.70 Fr to a day high of 1.80 Fr. Addex Therapeutics' stock is owned by many different institutional and retail investors. As of February 26th, there was short interest totaling 6,600 shares, an increase of 57.1% from the February 11th total of 4,200 shares. Identify stocks that meet your criteria using seven unique stock screeners. All rights reserved. Addex Therapeutics employs 19 workers across the globe. ), Addex Therapeutics has received 0 “underperform” votes. View which stocks have been most impacted by COVID-19. Addex Therapeutics' mailing address is CHEMIN DES AULX 12 PLAN-LES-OUATES, GENEVA V8, CH-1228. Its lead programs include Dipraglurant for the treatment of Parkinson's disease levodopa-induced dyskinesia, and dystonia; ADX71149 for epilepsy and undisclosed CNS disorders; and GABAB PAM for addiction. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2019 and/or its affiliates. Top institutional shareholders include Caxton Corp (4.86%). Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Investors can use this forecasting interface to forecast Addex Therapeutics historical stock prices and determine the direction of Addex Therapeutics's future trends based on various well-known forecasting models. See what's happening in the market right now with MarketBeat's real-time news feed. Post-Market 0.61 (5.51%) Learn more. No spam, we promise. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. AC Investment Inc. delivers machine learning based share price forecast. Find the latest Addex Therapeutics Ltd (ADXN) stock quote, history, news and other vital information to help you with your stock trading and investing. Addex American Depository Shares (ADS) representing 6 shares trade on the NASDAQ under the stock symbol ADXN. >> As of 2020 December 15, Tuesday current price of ADXN stock is 1.720$ and our data indicates that the asset price has been stagnating for the past 1 year (or since its inception). Sign up for free to our mailing list and receive news and updates. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. Vote “Underperform” if you believe ADXN will underperform the S&P 500 over the long term. Addex Therapeutics trades on the NASDAQ under the ticker symbol "ADXN.". Most stock quote data provided by BATS. Since then, ADXS stock has increased by 20.0% and is now trading at $0.80. A high-level overview of Addex Therapeutics Ltd (ADXN) stock. With a 5-year investment, the revenue is expected to be around +146.71%. All rights reserved. Factset: FactSet Research Systems Inc.2019. Only 0.34% of the stock of Addex Therapeutics is held by institutions. Want to see which stocks are moving? ADDEX N (ADXN.SW) stock forecast and price target. All rights reserved. In the short term (2weeks), ADXS's stock price should outperform the market by 0.33%.During that period the price should oscillate between -8.37% and +11.13%.. View which stocks are hot on social media with MarketBeat's trending stocks report. Stock Market Forecast: I Know First S&P 500 & Nasdaq Evaluation Report – Accuracy Up To 72%; Top S&P 500 Stocks Performance Report By Day Of The Week By I Know First Evaluation; MU Stock Forecast: I Know First Stock Forecasts Evaluation Report; Nvidia Stock Predictions: I Know First Stock Forecasts Evaluation Report Do Not Sell My Information. Addex Therapeutics has a market capitalization of $59.02 million and generates $2.78 million in revenue each year. 1. The Aden Forecast. Addex Therapeutics saw a drop in short interest in the month of February. Addex Therapeutics Ltd Stock Price ADXN Stock Price Today. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. In the Green. Addex Therapeutics Ltd was founded in 2002 and is headquartered in Geneva, Switzerland. (RTTNews) - What's moving these stocks in pre-market hours today? St. Louis, MO 63179-9927. Disclaimer. Your current $100 investment may be up to $246.71 in 2026. Not ready to subscribe just yet? The company focuses on the discovery of oral small molecule allosteric modulators of G-protein coupled receptors. ADXN Buy or Sell?Find out if you should buy ADXN stock. Standard & Poor's and S&P are registered trademarks of Standard & Poor's Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC.
In Welcher Liga Spielt Das Farmteam Tg S Oliver Würzburg, Myanmar Job Vacancy Website, Rinderhaltung Deutschland Privat, Bieco Holz Gym Betty, Bergischer Hc Logo, Ralf Rangnick Gladbach, Vfl Lübeck-schwartau Geschäftsstelle, Lidocain Salbe Kaufen, Guess Seductive Noir Parfum,